ORLANDO, Fla., Feb. 24, 2016 /PRNewswire/ -- XYMOGEN, the Orlando-based health sciences company, has earned Australia's prestigious certification from the Therapeutic Goods Administration (TGA), that country's equivalent to the U.S. Federal Drug Administration.
TGA certification is internationally recognized for having one of the world's most rigorous GMP audit processes in the dietary supplement industry, standards that are very similar to pharmaceutical-level GMP requirements. XYMOGEN's team spent two years of intense work and dedication in order to earn the certification.
Specifically, according to TGA requirements, XYMOGEN had to demonstrate the strictest level of adherence to manufacturing and quality standards and practices. TGA requirements exceed those established by the FDA.
"This is an important milestone for us and validates our focus and commitment to the manufacture and quality of dietary supplements," said Brian Blackburn, XYMOGEN founder and CEO. "It matters to us that we adhere to and uphold the highest manufacturing standards to ensure the highest level of quality. It's our culture and it's why our clients trust XYMOGEN."
Blackburn added that the company's work toward receiving the prestigious certification included collaboration from every department in the manufacturing company as well as a shared focus on the highest level of quality.
XYMOGEN, a family-owned health-sciences company headquartered in Orlando, Fla., has been providing high-quality dietary supplements to licensed health care practitioners for more than a quarter century. The nutraceutical company has introduced numerous innovations to the functional medicine community; its Medical Board of Advisors consists of clinical practitioners who are industry experts in a broad range of specialties. XYMOGEN's strength as a company has been reinforced eight of the last nine years, as it was recognized again in 2015 by Inc. magazine as one of the 5000 fastest-growing, best-run, most innovative and most inspiring private companies in America. The company's 136,000 square-foot manufacturing facility is GMP (good manufacturing practices) and GMP for Sport Athletic Banned Substances Program registered by NSF International and TGA Certified.
For more information, visit www.xymogen.com. Please email pr@xymogen for comments or inquiries.
Distributed by Sara Brady Public Relations, Inc.
222 W. Comstock Avenue, Suite 215
Winter Park, Florida 32789
CONTACT: Sarah Brady, 407-702-6632, firstname.lastname@example.org